ORCL— AI Stock Forecast & Price Targets
Published 6/29/2026 · A free sample of K3vl4r’s AI-powered analysis.
Kronos price forecasts, scored fundamentals & technicals, and a multi-horizon plan.
View the live ORCL price forecast →
Oracle has collapsed ~57% from its $345 high to $148 amid AI-capex digestion fears and an OpenAI IPO delay narrative, leaving the stock deeply oversold (RSI 29.6, -27% vs 200-SMA) and trading at a forward P/E of 13.6x with a PEG of 0.52 — cheap for a hyperscaler-adjacent name. However, free cash flow has gone sharply negative (-$24.5B TTM) as capex explodes to fund AI infrastructure buildouts, and debt-to-equity of 3.94x raises legitimate balance sheet questions. We see this as an ACCUMULATE setup for patient capital: the fundamentals justify a multi-year long, but near-term technicals remain broken and the Kronos forecast band is unreliable here (beaten by naive baseline on 1d).
1-4 weeks: Tactical long bias for an oversold bounce. RSI 29.6 + price 24% below SMA20 + 52-wk low only 10% away is classic mean-reversion setup. Entry zone $140-150, stop on a daily close below $134 (52-wk low invalidation). First target $170 (gap fill / prior support-turned-resistance), stretch $185-195 where the Kronos band tops out and SMA50 likely sits. Keep size modest (1/3 of intended position) given the reliability of the AI forecast is weak (beaten by naive baseline) and the trend is still down on every timeframe.
1-6 months: Accumulate on weakness. Thesis: $51B debt-funded AI capex either starts converting to OCI revenue/backlog burn (re-rate higher) or it doesn't (further derating). Earnings on Jun 10 already happened; next earnings (Sep) is the catalyst — watch RPO growth, OCI revenue growth and capex guidance. Expected return range: -15% to +40% from $148. Base case PT $180-200 (forward P/E rerate to 16-18x on $11 fwd EPS). Mind-changers: any OpenAI contract restructuring/cancellation, FCF deteriorating further than -$25B run-rate, or RPO growth deceleration below 30%.
1-3 years: Constructive. Oracle has structurally repositioned from legacy database/license to AI infrastructure provider with sticky enterprise relationships, defense/healthcare verticals expanding, and a differentiated OCI offering at lower cost than the big three hyperscalers. If 26% 5Y EPS growth (consensus) is anywhere close to right, the stock at 13.6x fwd is materially mispriced. Biggest structural risk: hyperscaler price competition compressing OCI margins, and customer concentration (OpenAI is too large a share of the backlog). 3-year fair value $250-300 if execution holds.
Revenue growth is accelerating meaningfully — Q/Q sales growth of 20.6% and TTM sales up 17.4% materially outpace the 3/5Y trend of ~10.5%, reflecting OCI/AI cloud demand. FY26 revenue of $67.4B with gross margin ~65.8% and operating margin 36.2% is solid, and ROE of 53% is excellent (though flattered by leverage). The break in the story is cash flow: TTM operating cash flow is $32B but capex has ballooned (latest quarters: -$8.5B, -$12B, -$18.6B, -$16.5B) producing -$24.5B in TTM FCF. Total debt has surged from $105B (Aug-25) to $156B (May-26) — a ~$51B increase in nine months funding AI infrastructure — while stockholders' equity sits at only $42.5B (D/E 3.94x). Forward P/E of 13.6x and PEG of 0.52 look attractive if Oracle converts these capex dollars into the contracted AI revenue backlog management has been touting; if utilization disappoints, the leverage cuts hard the other way. Profit margin of 25.2% and EPS Y/Y of 33% show the core business is still healthy.
Across all four timeframes, the chart is decisively broken. The 1d/4h views show a near-vertical collapse from ~$250 in early June to $148 by end-June, with price -22% MoM, -19% WoW, -24% YTD and -57% from the 52-week high of $345.72. Price sits -24% below SMA20, -21% below SMA50 and -27% below SMA200 — classic capitulation positioning, with RSI 29.6 confirming oversold but not yet a buy trigger on its own. Support is being tested at the $134-148 zone (52-wk low $134.57, only 10% below current). The Kronos forecast band on 1d shows a bounce to ~$190-200 over the next ~3 weeks (forecast $193.63), but reliability is poor here — directional accuracy 75% vs 95% naive baseline, so the model is essentially being beaten by 'tomorrow looks like today.' The 1wk forecast is contrarian (bullish_prob 0.20) and points to consolidation around $130-170 longer term. Net: oversold bounce is plausible to $170-190 resistance, but the multi-month trend has not reversed.
The dominant signal is the OpenAI IPO delay report (Barchart/Yahoo, Jun 26) — given Oracle's heavily-marketed multi-tens-of-billions OpenAI compute deal, any slippage in OpenAI's monetization timeline directly threatens ORCL's AI revenue recognition story and is the proximate cause of the recent leg lower. Offsetting this, Jefferies (Brent Thill) reiterated Buy with a $320 PT on Jun 23, citing continued strong cloud demand, and Oracle announced expansion into defense (third Defense Ecosystem cohort) and healthcare AI partnerships (Baystate Health, Theator) — incremental but real diversification of the AI revenue base beyond a single hyperscaler customer. Noise: the Iger/Kushner NBA bid and broader macro/crypto headlines are unrelated. The Whitehouse $15-50K sell is immaterial. Crowd sentiment is 88% bullish on Stocktwits, which in a stock down 30% YTD is a mild contrarian warning — retail is catching falling knives.
- OCI/AI infrastructure ramp — TTM sales growth accelerated to 17.4% from a 10.5% 3-yr trend; latest quarter +20.6% Q/Q points to backlog beginning to convert
- Defense Ecosystem third cohort launch (Jun 27) — AI, cyber, edge tech firms supporting national security/allied defense programs, a verticalized govt revenue stream
- Healthcare AI partnerships expanding (Baystate Health, Theator) — clinical operations, patient engagement, documentation automation; leverages Cerner acquisition
- Jefferies $320 PT (Jun 23) reiterated on continued strong cloud demand — sell-side conviction remains intact despite the price action
- $11 forward EPS vs $5.84 trailing implies analysts expect ~87% EPS expansion forward — if delivered, the 13.6x fwd P/E is a deep value setup for a growth name
- Fusion Cloud ERP/HCM/SCM applications suite continues to take share from on-premise legacy ERP — durable secular tailwind
- OpenAI IPO delay narrative (Jun 26) — Oracle's headline AI backlog is heavily concentrated in OpenAI compute; any monetization slippage is a direct revenue/recognition risk
- Free cash flow has collapsed to -$24.5B TTM as capex scales to $55B+ run-rate — if AI revenue doesn't ramp into this capacity, returns on incremental capital will be poor
- Debt-to-equity 3.94x and $156B total debt up $51B in 9 months — balance sheet is being stretched to fund the AI bet; rate environment matters
- Technical trend is decisively broken across every timeframe — -57% from highs, below all major SMAs, no confirmed reversal pattern yet, knife-catching risk is real
- Crowd sentiment 88% bullish on Stocktwits despite -30% YTD is a contrarian red flag — retail has not yet capitulated
- Kronos model directional accuracy (75%) is being beaten by the naive baseline (95%) on the 1d horizon — model unreliable in this regime, do not lean on the forecast
- Hyperscaler competition (AWS, Azure, GCP) on AI compute pricing could compress OCI margins as the segment scales
- Forward EPS of $10.92 implies ~87% growth — if delivery falls short, the valuation cushion disappears quickly
Get AI analysis on any stock
This is one of hundreds of Kronos AI reports — scored fundamentals & technicals, bull/base/bear price targets, a multi-horizon plan, and continuously-updated forecasts across the market. Create a free account to explore them all.
Create your free account →Already a member? Sign in · Join our Discord